Healthcare AI company Suki announced $90 million in financing on October 13, 2026, as part of its Series E. The California-based startup will use the capital to develop AI agents for clinical, administrative, and financial tasks. The investment supports its evolution from automated medical documentation toward connected healthcare workflows.
New Investors Support Expansion
New investors Healthier Capital, Crosslink Capital, and Hercules Capital participated in the financing. Returning backers include Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures. Suki did not disclose an updated valuation or specify the mix of financing instruments behind the $90 million.
Healthier Capital partner Aman Mahajan will join Suki’s board of directors following the transaction. His background includes clinical medicine and leadership experience at UPMC and UCLA Health. The appointment comes as Suki seeks to expand technology that operates within existing healthcare systems instead of creating standalone applications.
From Clinical Notes to Broader Healthcare Tasks
Founded in 2017 by Punit Soni, Suki initially focused on reducing physicians’ documentation workload. Its ambient clinical intelligence technology converts patient conversations into structured medical notes. The platform now extends into medical coding, clinical reasoning, revenue cycle management, and operational tasks that follow patient encounters.
The company distributes its technology through two products serving different customers. Suki for Clinicians provides AI assistance directly to medical professionals, while Suki for Partners offers APIs and software development kits for healthcare technology companies. This approach allows Suki to reach users through its own application and third-party platforms.
Adoption and Revenue Growth
Suki reports serving more than 450 healthcare organizations and working with over 30 technology partners. The company said patient encounters supported by its platform rose more than 190% year over year in 2026. It did not provide the underlying encounter count, limiting independent interpretation of that growth rate.
Revenue doubled in 2025, according to Suki, which expects similar growth in 2026. Its partner business has experienced more than tenfold revenue growth over the past two years. While the figures suggest commercial momentum, the company has not disclosed corresponding revenue totals in the financing announcement.
New Clinical Reasoning Capabilities
The financing follows Suki’s October 8 introduction of Ask, developed using Wolters Kluwer’s UpToDate Expert AI. The feature lets clinicians request patient details and evidence-based clinical information through natural-language questions. It works within Suki for Clinicians across electronic health record systems including Epic, Oracle Health, athenahealth, and MEDITECH.
Ask can retrieve medical context and return answers grounded in UpToDate’s clinical reference content. Supporting citations help clinicians assess the information without leaving their established workflow. The launch demonstrates Suki’s efforts to combine documentation with clinical decision support, rather than treating them as separate software functions.
Building the Next Generation of AI Agents
Suki intends to invest the financing in AI development, sales capabilities, and technology partnerships. Founder and CEO Punit Soni has outlined plans for agents that could coordinate referrals, schedule follow-ups, and carry out tasks arising from appointments. Those plans extend beyond the documentation features that established Suki’s initial market presence.
Healthcare organizations often rely on separate systems for clinical records, billing, and administrative operations. Suki aims to connect those processes so information can move more easily between staff and software applications. Its ability to deliver that vision will depend on integrations and demonstrated performance in real clinical environments.
Suki’s $90 million financing marks another step in its transition from AI medical note-taking to broader healthcare automation. Its expanding partner network and newly launched clinical reasoning feature create additional opportunities to integrate the technology into care delivery. The company’s next challenge is proving these capabilities translate into sustained operational improvements.